In 2014, MAPS spun out a separate division to immediate exploration and prepare for an eventual FDA application, which it submitted at the conclusion of last yr. In early 2024, that offshoot was renamed Lykos Therapeutics. Harm Reduction**: Hurt reduction methods purpose to attenuate the challenges connected with LSD use. https://jaidenzinor.ltfblog.com/30168009/wonder-bar-chocolate-mushroom-an-overview